Read the latest news about Alfa Study, the research platform at the Barcelonaβeta Brain Research Center (BBRC) to identify early pathophysicological characteristics of Alzheimer's disease to develop prevention strategies.
It is the largest neuroimaging study conducted in healthy individuals who carry the APOE-Ɛ4 gene variant, which confers risk for developing Alzheimer’s disease
The study was carried out based on the data obtained in the epidemiological questionnaires responded by the participants of the Alfa Study
BBRC researchers presented the latest advances of the Alfa Study and the Barcelonaβeta Dementia Prevention Research Clinic, in Chicago.
The Scientific Director of the Alzheimer's Prevention Program participated in a congress in Kyoto and in a conference at the University of Tokyo.